First Time Loading...

Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 30.75 USD -2.38% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

TWST's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. [ Read More ]

The intrinsic value of one TWST stock under the Base Case scenario is 48.96 USD. Compared to the current market price of 30.75 USD, Twist Bioscience Corp is Undervalued by 37%.

Key Points:
TWST Intrinsic Value
Base Case
48.96 USD
Undervaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Twist Bioscience Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling TWST stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Twist Bioscience Corp

Provide an overview of the primary business activities
of Twist Bioscience Corp.

What unique competitive advantages
does Twist Bioscience Corp hold over its rivals?

What risks and challenges
does Twist Bioscience Corp face in the near future?

Has there been any significant insider trading activity
in Twist Bioscience Corp recently?

Summarize the latest earnings call
of Twist Bioscience Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Twist Bioscience Corp.

Provide P/S
for Twist Bioscience Corp.

Provide P/E
for Twist Bioscience Corp.

Provide P/OCF
for Twist Bioscience Corp.

Provide P/FCFE
for Twist Bioscience Corp.

Provide P/B
for Twist Bioscience Corp.

Provide EV/S
for Twist Bioscience Corp.

Provide EV/GP
for Twist Bioscience Corp.

Provide EV/EBITDA
for Twist Bioscience Corp.

Provide EV/EBIT
for Twist Bioscience Corp.

Provide EV/OCF
for Twist Bioscience Corp.

Provide EV/FCFF
for Twist Bioscience Corp.

Provide EV/IC
for Twist Bioscience Corp.

Show me price targets
for Twist Bioscience Corp made by professional analysts.

What are the Revenue projections
for Twist Bioscience Corp?

How accurate were the past Revenue estimates
for Twist Bioscience Corp?

What are the Net Income projections
for Twist Bioscience Corp?

How accurate were the past Net Income estimates
for Twist Bioscience Corp?

What are the EPS projections
for Twist Bioscience Corp?

How accurate were the past EPS estimates
for Twist Bioscience Corp?

What are the EBIT projections
for Twist Bioscience Corp?

How accurate were the past EBIT estimates
for Twist Bioscience Corp?

Compare the revenue forecasts
for Twist Bioscience Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Twist Bioscience Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Twist Bioscience Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Twist Bioscience Corp compared to its peers.

Compare the P/E ratios
of Twist Bioscience Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Twist Bioscience Corp with its peers.

Analyze the financial leverage
of Twist Bioscience Corp compared to its main competitors.

Show all profitability ratios
for Twist Bioscience Corp.

Provide ROE
for Twist Bioscience Corp.

Provide ROA
for Twist Bioscience Corp.

Provide ROIC
for Twist Bioscience Corp.

Provide ROCE
for Twist Bioscience Corp.

Provide Gross Margin
for Twist Bioscience Corp.

Provide Operating Margin
for Twist Bioscience Corp.

Provide Net Margin
for Twist Bioscience Corp.

Provide FCF Margin
for Twist Bioscience Corp.

Show all solvency ratios
for Twist Bioscience Corp.

Provide D/E Ratio
for Twist Bioscience Corp.

Provide D/A Ratio
for Twist Bioscience Corp.

Provide Interest Coverage Ratio
for Twist Bioscience Corp.

Provide Altman Z-Score Ratio
for Twist Bioscience Corp.

Provide Quick Ratio
for Twist Bioscience Corp.

Provide Current Ratio
for Twist Bioscience Corp.

Provide Cash Ratio
for Twist Bioscience Corp.

What is the historical Revenue growth
over the last 5 years for Twist Bioscience Corp?

What is the historical Net Income growth
over the last 5 years for Twist Bioscience Corp?

What is the current Free Cash Flow
of Twist Bioscience Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Twist Bioscience Corp.

Financials

Balance Sheet Decomposition
Twist Bioscience Corp

Current Assets 390.2m
Cash & Short-Term Investments 311.1m
Receivables 35.4m
Other Current Assets 43.7m
Non-Current Assets 342.6m
PP&E 195.3m
Intangibles 139m
Other Non-Current Assets 8.3m
Current Liabilities 65.2m
Accounts Payable 9.3m
Accrued Liabilities 49.6m
Other Current Liabilities 6.4m
Non-Current Liabilities 77.5m
Other Non-Current Liabilities 77.5m
Efficiency

Earnings Waterfall
Twist Bioscience Corp

Revenue
262.4m USD
Cost of Revenue
-168.5m USD
Gross Profit
93.9m USD
Operating Expenses
-297.2m USD
Operating Income
-203.3m USD
Other Expenses
-2.5m USD
Net Income
-205.8m USD

Free Cash Flow Analysis
Twist Bioscience Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

TWST Profitability Score
Profitability Due Diligence

Twist Bioscience Corp's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
Exceptional Revenue Growth Forecast
29/100
Profitability
Score

Twist Bioscience Corp's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

TWST Solvency Score
Solvency Due Diligence

Twist Bioscience Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Twist Bioscience Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TWST Price Targets Summary
Twist Bioscience Corp

Wall Street analysts forecast TWST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TWST is 40.93 USD with a low forecast of 25.25 USD and a high forecast of 50.4 USD.

Lowest
Price Target
25.25 USD
18% Downside
Average
Price Target
40.93 USD
33% Upside
Highest
Price Target
50.4 USD
64% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

TWST Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

TWST Price
Twist Bioscience Corp

1M 1M
-10%
6M 6M
+101%
1Y 1Y
+141%
3Y 3Y
-78%
5Y 5Y
-7%
10Y 10Y
+120%
Annual Price Range
30.75
52w Low
11.49
52w High
41.5
Price Metrics
Average Annual Return 97.95%
Standard Deviation of Annual Returns 293.51%
Max Drawdown -94%
Shares Statistics
Market Capitalization 1.8B USD
Shares Outstanding 57 820 000
Percentage of Shares Shorted 27.8%

TWST Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Twist Bioscience Corp Logo
Twist Bioscience Corp

Country

United States of America

Industry

Biotechnology

Market Cap

1.8B USD

Dividend Yield

0%

Description

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 652 full-time employees. The company went IPO on 2018-10-31. The firm has developed a Twist Bioscience DNA synthesis platform to industrialize the engineering of biology. The core of its platform is a technology that provides a new method of manufacturing synthetic DNA by writing DNA on a silicon chip. The firm has developed multiple products derived from synthetic DNA and its versatile DNA synthesis technology. The company consists of two product lines, synthetic biology tools and NGS tools, that address different needs of its customers across a range of applications, such as synthetic genes, oligo pools, SARS-CoV-2 tools, and DNA libraries. Its synthetic biology products include Synthetic genes, Clonal genes in a Twist Bioscience, Non-clonal genes, Oligonucleotide or Oligo, pools, and Oligo pools for CRISPR gene editing. The NGS products are used for diagnostic tests for various indications like SARS-CoV-2 and cancer through liquid biopsy.

Contact

CALIFORNIA
South San Francisco
681 Gateway Blvd.
+18007190671.0
https://www.twistbioscience.com/

IPO

2018-10-31

Employees

652

Officers

Co-Founder, Chairman & CEO
Dr. Emily Marine Leproust Ph.D.
President & COO
Dr. Patrick John Finn Ph.D.
Senior Vice President of Human Resources
Ms. Paula Green
Senior VP of Advanced Development, GM of Data Storage & Director
Dr. William Charles Banyai Ph.D.
Chief Financial Officer
Mr. Adam Laponis
VP & Chief Accounting Officer
Mr. Robert F. Werner
Show More
Chief Technology Officer
Mr. Siyuan Chen
Chief Scientific Officer
Dr. Aaron K. Sato Ph.D.
Chief Information Officer
Mr. Chet Gandhi
Senior VP, Chief Legal Officer & Corporate Secretary
Mr. Dennis Cho
Show Less

See Also

Discover More
What is the Intrinsic Value of one TWST stock?

The intrinsic value of one TWST stock under the Base Case scenario is 48.96 USD.

Is TWST stock undervalued or overvalued?

Compared to the current market price of 30.75 USD, Twist Bioscience Corp is Undervalued by 37%.